Frequency of liver test increases on abiraterone acetate in men with castrate-resistant prostate cancer (CRPC): Natural history, management, and outcome.

被引：0
|
作者：
Colomba, Emeline
Marret, Gregoire
Baciarello, Giulia
Massard, Christophe
Loriot, Yohann
Albiges, Laurence
Carton, Edith
Alexandre, Jerome
Huillard, Olivier
Culine, Stephane
Fizazi, Karim
机构：
[1] Univ Paris Sud, Gustave Roussy Inst Oncol, Villejuif, France
[2] St Louis Hosp, Paris, France
[3] Gustave Roussy Canc Campus, Villejuif, France
[4] Inst Gustave Roussy, Villejuif, France
[5] Univ Paris 05, Hop Cochin, CARPEM, AP HP, Paris, France
[6] Paris Descartes Univ, Cochin Hosp, Immunomodulatory Therapies Multidisciplinary Stud, AP HP,CARPEM, Paris, France
[7] Hosp St Louis, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.332
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
332
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Identification of an androgen withdrawal responsive phenotype in castrate resistant prostate cancer (CRPC) patients (pts) treated with abiraterone acetate (AA)
    Logothetis, C. J.
    Wen, S.
    Molina, A.
    Chieffo, N.
    Smith, L. A.
    Troncoso, P.
    Efstathiou, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] A phase Ib study of BKM120 combined with abiraterone acetate for castrate-resistant, metastatic prostate cancer.
    Patnaik, Akash
    Kung, Justin
    Loda, Massimo
    Taplin, Mary-Ellen
    Lis, Rosina
    Kantoff, Philip W.
    Balk, Steven P.
    Bubley, Glenn J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [33] A phase Ib study of BKM120 combined with abiraterone acetate for castrate-resistant, metastatic prostate cancer.
    Patnaik, Akash
    Loda, Massimo
    Kung, Justin
    Wu, Jim
    Taplin, Mary-Ellen
    Kantoff, Philip W.
    Cantley, Lewis
    Balk, Steven P.
    Bubley, Glenn J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] A retrospective study on cabazitaxel and abiraterone acetate sequential treatment (CAST) in docetaxel treated metastatic castrate-resistant prostate cancer patients
    Wissing, M. D.
    Coenen, J. L. L. M.
    Van den Berg, P.
    Van Oort, I. M.
    De Wit, R.
    Bergman, A. M.
    Westgeest, H. M.
    Hamberg, P.
    Los, M.
    Gelderblom, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S698 - S698
  • [35] CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel
    Wissing, Michel D.
    Coenen, Jules L. L. M.
    van den Berg, Pieter
    Westgeest, Hans M.
    van den Eertwegh, Alfons J. M.
    van Oort, Inge M.
    Bos, Monique M.
    Bergman, Andre M.
    Hamberg, Paul
    ten Tije, Albert J.
    Los, Maartje
    Lolkema, Martijn P. J. K.
    de Wit, Ronald
    Gelderblom, Hans
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (06) : E760 - E772
  • [36] A model for predicting overall survival in men with metastatic castrate-resistant prostate cancer (CRPC) for whom first-line chemotherapy failed
    Halabi, Susan
    Lin, Chen-Yen
    Small, Eric Jay
    Armstrong, Andrew J.
    Kaplan, Ellen B.
    Petrylak, Daniel Peter
    Sternberg, Cora N.
    Shen, Liji
    Oudard, Stephane
    De Bono, Johann Sebastian
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [37] Survival outcomes for men with castrate-resistant prostate cancer (CRPC) treated with a dendritic-cell based vaccine in a randomized controlled trial
    Gardiner, R. A.
    Mactaggart, P.
    Yaxley, J.
    Nicol, D.
    Mcclintock, S.
    Ellem, K.
    Hart, D.
    Seymour, G. J.
    Lopez, A.
    Schmidt, C.
    BJU INTERNATIONAL, 2014, 113 : 34 - 35
  • [38] Very Fast Recovery of Acute Disseminated Intravascular Coagulation with Abiraterone Acetate in a Patient with Bone Metastases from Castrate-Resistant Prostate Cancer
    Gauthier, Helene
    Serrate, Camille
    Pouessel, Damien
    le Maignan, Christine
    Teixeira, Luis
    Culine, Stephane
    CASE REPORTS IN ONCOLOGY, 2014, 7 (03): : 625 - 627
  • [39] Cardiac Biomarkers and Geriatric Assessment in Metastatic Castrate-Resistant Prostate Cancer During Abiraterone Acetate Therapy - A Cardio-Oncology Study
    Wilk, Michal
    Wasko-Grabowska, Anna
    Skoneczna, Iwona
    Szczylik, Cezary
    Szmit, Sebastian
    CANCER CONTROL, 2022, 29
  • [40] SURVIVAL OUTCOMES FOR MEN WITH CASTRATE-RESISTANT PROSTATE CANCER (CRPC) TREATED WITH A DENDRITIC-CELL BASED VACCINE IN A RANDOMIZED CONTROLLED TRIAL
    Gardiner, R. A.
    Mactaggart, P.
    Yaxley, J.
    Nicol, D.
    McClintock, S.
    Ellem, K. A. O.
    Hart, D.
    Seymour, G. J.
    Lopez, A.
    Schmidt, C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 33 - 34
12345